ESTRO 2023 - Abstract Book

S872

Digital Posters

ESTRO 2023

In May 2021 the Irish Health Service Executive’s IT services was victim of an organised ransomware attack. National hospital IT systems were shut down while the damage was assessed and repaired. In Cork University Hospital (CUH) radiotherapy department, 101 patients had their treatment disrupted with no immediately foreseeable date for recommencement of services. This study assesses the logistical and radiobiological impact of this gap in radiotherapy for a large group of patients and the efficacy of compensation strategies. Materials and Methods Radiotherapy for high-risk patients was recommenced in a neighbouring private hospital. Remaining patients could be restarted in CUH when systems became operational after 21 days. New CT simulation and radiotherapy plans were required for transferred patients. We calculated the planned total duration and actual duration of each patients’ treatment. A planned biological equivalent dose (BED) and actual BED was calculated for each treatment course dependent on tumour type. Treatment acceleration, bi-daily treatment and extra fractions were employed as compensation strategies. We calculated the BED lost and potential BED saved per patient. Results The mean gap in treatment for the cohort was 16 days (11-28) Patients had a cumulative 1200 fractions of their treatment course remaining. 44 patients were transferred to the private hospital. Mean time from new CT to start was 4.8 days (3 10). The mean number of days saved by compensation strategies was 3 (0-10) per patient. The potential Gray lost overall was 803Gy, mean 8.46Gy per patient (0- 19.8Gy). The total Gray saved was 276Gy, mean 2.9Gy (0-9Gy) saved per patient.

Conclusion Large scale disruption of a radiotherapy service is uncommon and this malicious act of cybercrime had a significant and sudden impact on patient care. Through multi-departmental and multi-institutional co-operation potential quantifiable harm to patients was limited. Unfortunately, the full effects of this crime may take years to manifest and long term follow up is essential to assess any potential negative oncological outcomes. This crisis highlights the need for robust IT infrastructure and contingencies to allow continuation of critical radiotherapy services in the inevitable event of future cyber-attacks.

PO-1090 Current Situation of Brachytherapy in Turkey

A. Ozen 1

1 On behalf of the Turkish Society of Radiation Oncology Brachytherapy Group, Eskisehir Osmangazi University, Department of Radiation Oncology, Eskisehir, Turkey Purpose or Objective Brachytherapy is an important part of cancer treatment. We aimed to evaluate the current situation of brachytherapy treatment in Turkey according to the information received from the members of the Turkish Society of Radiation Oncology Brachytherapy Group. Materials and Methods To achieve our purpose, we sent an excel data sheet to the group members to identify and record the brachytherapy capabilities of the centers in Turkey. Results According to the information obtained from the Turkish Radiation Oncology Society and International Atom Energy Agency website, we contacted 32 radiotherapy centers containing brachytherapy units, and 30 centers from Turkey and the Turkish Republic of Northern Cyprus shared their information. The facilities of the brachytherapy centers are listed in Table 1. The oldest brachytherapy center is established in 1935. All centers are associated with the university except one. 63% (n =19) of the centers are located in the 3 big cities such as Istanbul, Ankara, and Izmir. All centers reported that they perform 3 dimensional HDR brachytherapy using the Ir192 radioactive source. All centers perform gynecological brachytherapy. LDR brachytherapy is available in 2 centers. There is no center that performs PDR brachytherapy. There are only two centers applying eye plaque application. Although skin brachytherapy is the second most common application type for centers, Head and Neck, Lung, Prostate, STS, Esophagus, and Breast cancer are other brachytherapy indications of some centers. The mostly used fractionations are 4 fr x 7 Gy, 5 fr x 5.5 Gy, and 5 fr x 6 Gy in cervix cancer patients treated with definitively